SMTL ID : 3b9m.1

Human serum albumin complexed with myristate, 3'-azido-3'-deoxythymidine (AZT) and salicylic acid

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

6 x MYR: MYRISTIC ACID(Non-covalent)

MYR.1: 11 residues within 4Å: Chain A: L.115, R.117, M.123, Y.138, L.139, I.142, L.154, A.158, Y.161, F.165, R.186 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:Y.138, A:L.139, A:I.142, A:L.154, A:Y.161, A:F.165, A:F.165 Hydrogen bonds: A:L.115 Salt bridges: A:R.117, A:R.186 MYR.2: 13 residues within 4Å: Chain A: R.10, L.14, L.22, F.27, L.66, F.70, Y.150, P.152, L.251, A.254, R.257, L.283, S.287 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.14, A:L.22, A:F.27, A:L.66, A:F.70, A:P.152, A:L.251, A:A.254 Hydrogen bonds: A:Y.150, A:S.287 Salt bridges: A:R.257 MYR.3: 16 residues within 4Å: Chain A: S.342, V.344, L.345, R.348, I.388, N.391, F.403, L.407, L.430, G.431, G.434, A.449, L.453, R.485, P.486 Ligands: MYR.4 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.344, A:I.388, A:N.391, A:F.403, A:F.403, A:L.407, A:L.453, A:R.485 Salt bridges: A:R.348, A:R.485 MYR.4: 9 residues within 4Å: Chain A: N.391, R.410, Y.411, V.426, L.430, L.460, F.488, S.489 Ligands: MYR.3 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:Y.411, A:Y.411, A:Y.411, A:V.426, A:L.430, A:L.430, A:F.488, A:F.488 Hydrogen bonds: A:Y.411, A:S.489 Salt bridges: A:R.410 MYR.5: 9 residues within 4Å: Chain A: Y.401, F.502, F.507, K.525, L.529, L.532, V.547, F.551, S.579 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:F.502, A:F.507, A:K.525, A:L.529, A:L.532, A:F.551, A:F.551 Salt bridges: A:K.402, A:K.525 MYR.6: 6 residues within 4Å: Chain A: R.209, A.210, A.213, D.324, G.328, K.351 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:A.213, A:K.351

1 x AZZ: 3'-azido-3'-deoxythymidine(Non-covalent)

AZZ.7: 10 residues within 4Å: Chain A: Y.148, Y.150, E.153, K.195, Q.196, K.199, V.241, H.242, C.245, R.257 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:Y.150, A:K.195, A:Q.196, A:K.199 Hydrogen bonds: A:Y.148, A:E.153, A:Q.196, A:H.242, A:R.257

2 x SAL: 2-HYDROXYBENZOIC ACID(Non-covalent)

SAL.8: 4 residues within 4Å: Chain A: L.219, R.257, L.260, A.291 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:L.219, A:A.291 Salt bridges: A:R.257 SAL.9: 7 residues within 4Å: Chain A: I.142, H.146, F.157, Y.161, L.185, R.186, G.189 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:I.142, A:F.157, A:Y.161 Hydrogen bonds: A:Y.161, A:Y.161

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhu, L. et al., A new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography. J.Struct.Biol. (2008)

Release Date

2008-05-27

Peptides

Serum albumin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serum albumin

Related Entries With Identical Sequence